Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

324 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of antimicrobial resistance laboratory-based surveillance capacity of hospitals in Zambia: findings and implications for system strengthening.
Yamba K, Chizimu JY, Mudenda S, Lukwesa C, Chanda R, Nakazwe R, Simunyola B, Shawa M, Kalungia AC, Chanda D, Mateele T, Thapa J, Kapolowe K, Mazaba ML, Mpundu M, Masaninga F, Azam K, Nakajima C, Suzuki Y, Bakyaita NN, Wesangula E, Matu M, Chilengi R. Yamba K, et al. Among authors: chanda d. J Hosp Infect. 2024 Apr 15;148:129-137. doi: 10.1016/j.jhin.2024.03.014. Online ahead of print. J Hosp Infect. 2024. PMID: 38621513 Free article.
COVID-19 Vaccine Effectiveness Against Progression to In-Hospital Mortality in Zambia, 2021-2022.
Chanda D, Hines JZ, Itoh M, Fwoloshi S, Minchella PA, Zyambo KD, Sivile S, Kampamba D, Chirwa B, Chanda R, Mutengo K, Kayembe MF, Chewe W, Chipimo P, Mweemba A, Agolory S, Mulenga LB. Chanda D, et al. Among authors: chanda r. Open Forum Infect Dis. 2022 Sep 11;9(9):ofac469. doi: 10.1093/ofid/ofac469. eCollection 2022 Sep. Open Forum Infect Dis. 2022. PMID: 36196297 Free PMC article.
Mitigating antimicrobial resistance (AMR) using implementation research: a development funder's approach.
Khurana MP, Essack S, Zoubiane G, Sreenivasan N, Cordoba GC, Westwood E, Dalsgaard A, Mdegela RH, Mpundu M, Scotini R, Matondo AB, Mzula A, Chanishvili N, Gogebashvili D, Beruashvili M, Tsereteli M, Sooronbaev T, Kjærgaard J, Bloch J, Isaeva E, Mainda G, Muuka G, Mudenda NB, Goma FY, Chu DH, Chanda D, Chirwa U, Yamba K, Kapolowe K, Fwoloshi S, Mwenge L, Skov R. Khurana MP, et al. Among authors: chanda d. JAC Antimicrob Resist. 2023 Mar 27;5(2):dlad031. doi: 10.1093/jacamr/dlad031. eCollection 2023 Apr. JAC Antimicrob Resist. 2023. PMID: 36994233 Free PMC article. Review.
Antimicrobial Resistance Patterns and Risk Factors Associated with ESBL-Producing and MDR Escherichia coli in Hospital and Environmental Settings in Lusaka, Zambia: Implications for One Health, Antimicrobial Stewardship and Surveillance Systems.
Kasanga M, Kwenda G, Wu J, Kasanga M, Mwikisa MJ, Chanda R, Mupila Z, Yankonde B, Sikazwe M, Mwila E, Shempela DM, Solochi BB, Phiri C, Mudenda S, Chanda D. Kasanga M, et al. Among authors: chanda d, chanda r. Microorganisms. 2023 Jul 31;11(8):1951. doi: 10.3390/microorganisms11081951. Microorganisms. 2023. PMID: 37630511 Free PMC article.
First COVID-19 case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.
Simulundu E, Mupeta F, Chanda-Kapata P, Saasa N, Changula K, Muleya W, Chitanga S, Mwanza M, Simusika P, Chambaro H, Mubemba B, Kajihara M, Chanda D, Mulenga L, Fwoloshi S, Shibemba AL, Kapaya F, Zulu P, Musonda K, Monze M, Sinyange N, Mazaba ML, Kapin'a M, Chipimo PJ, Hamoonga R, Simwaba D, Ngosa W, Morales AN, Kayeyi N, Tembo J, Bates M, Orba Y, Sawa H, Takada A, Nalubamba KS, Malama K, Mukonka V, Zumla A, Kapata N. Simulundu E, et al. Among authors: chanda kapata p, chanda d. Int J Infect Dis. 2021 Jan;102:455-459. doi: 10.1016/j.ijid.2020.09.1480. Epub 2020 Oct 6. Int J Infect Dis. 2021. PMID: 33035675 Free PMC article.
Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.
Mfinanga S, Chanda D, Kivuyo SL, Guinness L, Bottomley C, Simms V, Chijoka C, Masasi A, Kimaro G, Ngowi B, Kahwa A, Mwaba P, Harrison TS, Egwaga S, Jaffar S; REMSTART trial team. Mfinanga S, et al. Among authors: chanda d. Lancet. 2015 May 30;385(9983):2173-82. doi: 10.1016/S0140-6736(15)60164-7. Epub 2015 Mar 10. Lancet. 2015. PMID: 25765698 Clinical Trial.
324 results